Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Brazilian integrated energy giant Petroleo Brasileiro S.A. or Petrobras (PBR - Analyst Report) announced that the second well drilled in the Jupiter area of Santos basin also confirmed the presence of natural gas and condensate in the region.
Petrobras drilled the well – 3-BRSA-967A-RJS (3-RJS-683A) – commonly known as Jupiter Nordeste in the ultra-deep waters of block BM-S-24 and at water depth of 7,089.9 feet. The well is 4.6 miles away from the first discovered well in Jupiter acreage and 170.9 miles off the coast of Rio de Janeiro.
The company stated that drilling of the second well is still ongoing and has reached a depth of 17,841.2 feet. Petrobras has identified a 577.4 feet thick oil column in the well that shows excellent permeability and porosity.
Stated-controlled Petrobras, with an 80% interest, acts as the operator of the exploration block, while Petrogal Brasil holds the remaining 20%.
As per the Appraisal Plan approved by the Oil, Natural Gas and Biofuels National Agency, Petrobras along with its partner will consistently conduct activities and investments required for the assessment of the area.
Headquartered in Rio de Janeiro, Petrobras operates in six segments: Exploration and Production, Refining, Transportation and Marketing, Distribution, Gas and Power, and Biofuels and International.
Petrobras – the fourth biggest company by market capitalization after Exxon Mobil Corp. (XOM - Analyst Report), Royal Dutch Shell plc (RDS.A - Analyst Report) and Chevron Corporation (CVX - Analyst Report) – currently retains a Zacks #4 Rank, which translates into a short-term Sell rating. We also maintain a long-term Underperform recommendation on the stock
We remain concerned regarding Petrobras’ exposure to the volatile oil and gas fundamentals, which are expected to impact profitability. Moreover, the company’s huge investment requirements, operational hindrances and international business risks also add to our negative sentiment.
Get the full Analyst Report on CVX - FREE
Get the full Analyst Report on RDS.A - FREE
Get the full Analyst Report on PBR - FREE
Get the full Analyst Report on XOM - FREE